Semler Scientific (NASDAQ:SMLR) Reaches New 52-Week High – Should You Buy?

Shares of Semler Scientific, Inc. (NASDAQ:SMLR) hit a new 52-week high during trading on Thursday . The stock traded as high as $74.85 and last traded at $74.85, with a volume of 322944 shares trading hands. The stock had previously closed at $59.27.

Semler Scientific Stock Down 4.2 %

The company has a market capitalization of $462.48 million, a P/E ratio of 31.05 and a beta of 0.92. The firm has a 50-day moving average price of $31.69 and a two-hundred day moving average price of $30.51.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million for the quarter.

Insider Activity

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. This trade represents a 14.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 30.20% of the company’s stock.

Hedge Funds Weigh In On Semler Scientific

Hedge funds have recently added to or reduced their stakes in the company. CWM LLC boosted its holdings in Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after buying an additional 744 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific in the second quarter valued at approximately $34,000. Quest Partners LLC acquired a new stake in Semler Scientific in the second quarter worth $59,000. Meeder Asset Management Inc. bought a new position in shares of Semler Scientific during the second quarter worth $67,000. Finally, US Bancorp DE grew its holdings in shares of Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares during the period. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.